Correlation Between Virpax Pharmaceuticals and Fresh Tracks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Fresh Tracks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Fresh Tracks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Fresh Tracks Therapeutics, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Fresh Tracks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Fresh Tracks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Fresh Tracks.

Diversification Opportunities for Virpax Pharmaceuticals and Fresh Tracks

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Virpax and Fresh is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Fresh Tracks Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fresh Tracks Therapeutics and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Fresh Tracks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fresh Tracks Therapeutics has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Fresh Tracks go up and down completely randomly.

Pair Corralation between Virpax Pharmaceuticals and Fresh Tracks

If you would invest  85.00  in Virpax Pharmaceuticals on August 13, 2024 and sell it today you would lose (9.00) from holding Virpax Pharmaceuticals or give up 10.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy1.56%
ValuesDaily Returns

Virpax Pharmaceuticals  vs.  Fresh Tracks Therapeutics

 Performance 
       Timeline  
Virpax Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Virpax Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Virpax Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Fresh Tracks Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fresh Tracks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Fresh Tracks is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Virpax Pharmaceuticals and Fresh Tracks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virpax Pharmaceuticals and Fresh Tracks

The main advantage of trading using opposite Virpax Pharmaceuticals and Fresh Tracks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Fresh Tracks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fresh Tracks will offset losses from the drop in Fresh Tracks' long position.
The idea behind Virpax Pharmaceuticals and Fresh Tracks Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance